BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8991544)

  • 1. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.
    Chiu CP; Dragowska W; Kim NW; Vaziri H; Yui J; Thomas TE; Harley CB; Lansdorp PM
    Stem Cells; 1996 Mar; 14(2):239-48. PubMed ID: 8991544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human hematopoietic progenitor cells.
    Hohaus S; Voso MT; Orta-La Barbera E; Cavallo S; Bellacosa A; Rutella S; Rumi C; Genuardi M; Neri G; Leone G
    Haematologica; 1997; 82(3):262-8. PubMed ID: 9234570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients.
    Vignoli M; Stecca B; Furlini G; Re MC; Mantovani V; Zauli G; Visani G; Colangeli V; La Placa M
    AIDS; 1998 Jun; 12(9):999-1005. PubMed ID: 9662195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decline in proliferative potential of purified stem cell candidates.
    Lansdorp PM; Dragowska W; Thomas TE; Little MT; Mayani H
    Blood Cells; 1994; 20(2-3):376-80; discussion 380-1. PubMed ID: 7538342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells.
    Hiyama K; Hirai Y; Kyoizumi S; Akiyama M; Hiyama E; Piatyszek MA; Shay JW; Ishioka S; Yamakido M
    J Immunol; 1995 Oct; 155(8):3711-5. PubMed ID: 7561072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M; Rottman GA; Shultz LD; Civin CI
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human telomerase reverse transcriptase in bone marrow CD34+ cells from patients with beta-thalassemia major.
    Li X; Qu Y; Mao M; Yu F; Li Q; Hua Y; Mu D
    Transfusion; 2008 Aug; 48(8):1627-33. PubMed ID: 18466174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
    Templin C; Kotlarz D; Rathinam C; Rudolph C; Schätzlein S; Ramireddy K; Rudolph KL; Schlegelberger B; Klein C; Drexler H
    Exp Hematol; 2008 Feb; 36(2):204-15. PubMed ID: 18206728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.